rs928293754
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 3P and 2B. PM2PP2BP4_Moderate
The NM_001081550.2(THOC2):c.1147A>G(p.Ile383Val) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000367 in 1,089,227 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 1 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 11/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001081550.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
THOC2 | ENST00000245838.13 | c.1147A>G | p.Ile383Val | missense_variant | Exon 11 of 39 | 5 | NM_001081550.2 | ENSP00000245838.8 | ||
THOC2 | ENST00000355725.8 | c.1147A>G | p.Ile383Val | missense_variant | Exon 11 of 39 | 5 | ENSP00000347959.4 | |||
THOC2 | ENST00000491737.5 | c.802A>G | p.Ile268Val | missense_variant | Exon 7 of 34 | 5 | ENSP00000419795.1 |
Frequencies
GnomAD3 genomes Cov.: 23
GnomAD3 exomes AF: 0.00000590 AC: 1AN: 169615Hom.: 0 AF XY: 0.0000176 AC XY: 1AN XY: 56687
GnomAD4 exome AF: 0.00000367 AC: 4AN: 1089227Hom.: 0 Cov.: 27 AF XY: 0.00000281 AC XY: 1AN XY: 355673
GnomAD4 genome Cov.: 23
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
The c.1147A>G (p.I383V) alteration is located in exon 11 (coding exon 11) of the THOC2 gene. This alteration results from an A to G substitution at nucleotide position 1147, causing the isoleucine (I) at amino acid position 383 to be replaced by a valine (V). Based on data from gnomAD, the G allele has an overall frequency of 0.001% (1/169615) total alleles studied. The highest observed frequency was 0.001% (1/77581) of European (non-Finnish) alleles. This amino acid position is not well conserved in available vertebrate species. This alteration is predicted to be tolerated by in silico analysis. Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at